Bli medlem
Bli medlem

Du är här


Navamedic ASA: Improved profitability for Navamedic

Navamedic ASA (OSE: NAVA) today announced the Company's second quarter 2015
financial results. Navamedic's profitability continued to improve, while
sales in the quarter were at par with last year.

After the end of the quarter Navamedic acquired the Swedish medtech company
Observe Medical International AB, which has developed the next generation
digital urine meter for use in intensive care, Sippi®. The innovative, patent
protected product has secured distribution in Germany and the Nordic markets
and holds global sales potential in a market worth approximately two Bn NOK,
Navamedic expects a strong future sales growth for Sippi®.

Navamedic had sales of NOK 59.6 million in the second quarter, compared to NOK
59.5 million last year. The Company's EBITDA for the quarter was NOK 3.5
million, compared to NOK 3.0 million the second quarter of 2014. Earnings
before taxes for the second quarter this year ended at NOK 1.0 million,
against NOK 0.2 million last year.

For the first half of 2015, sales ended at NOK121.5 million, against NOK 102.4
million last year, a sales growth of 19 per cent. EBITDA for the first half
was NOK 7.7 million, up from NOK 5.0 million last year. Earnings before taxes
for the first half came in at NOK 2.5 million, compared to NOK 0.5 million in

The improved profitability in 2015 is mainly due to a stronger focus on
prioritized products in Navamedics portfolio and new hospital contracts.

Going forward, Navamedic will focus on expanding and improving profitability
in its distribution business in the Nordic region, and on the international
launch of Sippi®.

For further information, please contact CEO Tom Rönnlund, telephone +46 727
320 321 or CFO Bjørn Lindholt, telephone +47 9300 6601.

Navamedic ASA is a Norwegian pharmaceutical products company, delivering
products to hospitals, pharmacies and health products stores in the Nordic
and Benelux markets. The Company operates three business areas; Pharma
Products, Medical Nutrition and Consumer Care based on its relationship with
a number of pharmaceutical products manufacturers. Observe Medical
International AB, a medical technology company offering the next generation
digital urine meter Sippi ®, is a wholly owned subsidiary. Navamedic is
listed on the Oslo Stock Exchange (ticker: NAVA).


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Navamedic ASA via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.